Pressemitteilungen zu dem Thema cannabinoids


Unterkategorien

PresseMitteilungen zu dem Schlagwort cannabinoids


Vitality Biopharma Completes Pivotal GMP Manufacturing Agreements for Cannabinoid Pharmaceuticals

LOS ANGELES, CA -- (Marketwired) -- 11/01/17 -- (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced completion of pivotal manufacturing agreements that enable the production of clinical-grade cannabinoid pharmaceuticals at its R&D facili ...


01.11.2017

Vitality Biopharma Announces Positive Results for Multiple Cannabinoid Drug Formulations in Treatment of IBD

LOS ANGELES, CA -- (Marketwired) -- 10/19/17 -- (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced additional positive preclinical efficacy results for the treatment of colitis.Vitality Biopharma has developed a new class of cannabinoid prodrugs, known as cannabosides, wh ...


19.10.2017

Vitality Biopharma Announces Publication of International PCT Patent Filing for Cannabinoid Pharmaceuticals

LOS ANGELES, CA -- (Marketwired) -- 10/16/17 -- (OTCQB: VBIO) ("Vitality" or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the publication of an international PCT patent application that covers a new class of cannabinoid pharmaceuticals.The publication of the international patent filing is the fi ...


16.10.2017

Vitality Biopharma Achieves Cannabinoid Pharmaceutical Biosynthesis Breakthrough

LOS ANGELES, CA -- (Marketwired) -- 10/04/17 -- (OTCQB: VBIO) ("Vitality Biopharma", "Vitality", or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the achievement of a biosynthesis breakthrough.Vitality has developed a proprietary biosynthesis technology that can modify cannabinoids in o ...


04.10.2017

Vitality Biopharma Receives Updated SeeThruEquity Price Target of $2.40

LOS ANGELES, CA -- (Marketwired) -- 09/27/17 -- (OTCQB: VBIO) ("Vitality", "Vitality Biopharma", or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, is pleased to advise that SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, ...


27.09.2017

Vitality Biopharma to Present at The MoneyShow San Francisco Conference

LOS ANGELES, CA -- (Marketwired) -- 08/23/17 -- (OTCQB: VBIO) ("Vitality", "Vitality Biopharma", or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, is pleased to provide a presentation and participate in a cannabis industry panel session at the MoneyShow San Francisco investment conference.Company CEO Ro ...


23.08.2017

Vitality Biopharma Releases Positive Results for Treatment of Inflammatory Bowel Disease

LOS ANGELES, CA -- (Marketwired) -- 07/19/17 -- (OTCQB: VBIO) ("Vitality" or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced positive preclinical efficacy results for its gut-targeted cannabosides in the treatment of colitis.Vitality Biopharma has developed a new class of cannabinoid prodrugs, know ...


19.07.2017

Vitality Biopharma Advisor to Present Pediatric IBD Case Study at ICRS2017 in Montreal

LOS ANGELES, CA -- (Marketwired) -- 06/21/17 -- (OTCQB: VBIO) ("Vitality Biopharma," "Vitality", or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, announced today that Company Advisor Dr. Natasha Ryz will be presenting at an international research symposium in Montréal, Canada.Dr. Ryz will provide a po ...


21.06.2017

RespireRx Pharmaceuticals Inc. to Present at the 2017 Marcum MicroCap Conference

GLEN ROCK, NJ -- (Marketwired) -- 06/14/17 -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the development of medicines for the treatment of respiratory disorders for which there are no approved pharmaceuticals, particularly sleep apneas and respiratory depression resulting from pain management medicines and disabilities such as spinal cord injury, announces that the Company''s President, Chief Executive Officer and Vice ...


14.06.2017

Vitality Biopharma to Present at the 7th Annual LD Micro Invitational

LOS ANGELES, CA -- (Marketwired) -- 05/30/17 -- (OTCQB: VBIO) ("Vitality Biopharma", "Vitality", or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced that it will be presenting at the 7th Annual LD Micro Invitational in Los Angeles.The corporate presentation is on Tuesday, June 6th at 9:00 ...


30.05.2017

Vitality Biopharma Announces Positive Results for Cannabinoid Antibiotics

LOS ANGELES, CA -- (Marketwired) -- 05/10/17 -- (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced that it has obtained positive results demonstrating antimicrobial activity of cannabinoids and filed for patent protection on the use of cannabinoid compounds for the treatme ...


10.05.2017

Vitality Biopharma Adds Key Clinical Advisors in Gastroenterology

LOS ANGELES, CA -- (Marketwired) -- 05/03/17 -- (OTCQB: VBIO) ("Vitality Biopharma," "Vitality", or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, is pleased to announce and welcomes the appointments of Dr. Douglas A. Drossman and Dr. Mark Gerich as clinical advisors with expertise in gastroenterology a ...


03.05.2017

Vitality Biopharma Appoints Pharma Industry Veteran to Advance Cannabosides Regulatory Development

LOS ANGELES, CA -- (Marketwired) -- 04/12/17 -- (OTCQB: VBIO) ("Vitality" or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the appointment of Tracy Rockney, J.D., Co-Founder & Chief Operating Officer, OneSource Regulatory, to the position of Senior Regulatory Advisor.Tracy Rockney, J.D. was f ...


12.04.2017

Vitality Biopharma Announces International Patent Filing for Neural Repair Treatments

LOS ANGELES, CA -- (Marketwired) -- 04/05/17 -- (OTCQB: VBIO) ("Vitality" or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the filing of an international patent application in March 2017 that describes compounds discovered to be effective in a drug screening model of neural repair.The underlying ...


05.04.2017

Vitality Biopharma Announces Positive Results for Colon Cancer

LOS ANGELES, CA -- (Marketwired) -- 03/30/17 -- (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced that it has positive results indicating a new use for the Company''s proprietary prodrug cannabinoid delivery platform.Multiple colon cancer cell types were screened ...


30.03.2017

Vitality Biopharma Announces Proprietary THC Pharmaceutical with Greatly Decreased Psychoactivity

LOS ANGELES, CA -- (Marketwired) -- 03/02/17 -- (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced that it has created a library of proprietary glycosides of THC (delta-9-tetrahydrocannabinol), the main psychoactive chemical found in cannabis or marijuana, which enable targ ...


02.03.2017

Vitality Biopharma to Present at SeeThruEquity 3rd Annual Innovations Investor Conference in Miami

LOS ANGELES, CA -- (Marketwired) -- 02/16/17 -- (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, is pleased to advise there will be a corporate presentation at the SeeThruEquity 3rd Annual Innovations Investor Conference to be held on Wednesday, February ...


16.02.2017

Vitality Biopharma Publishes Scientific Data on Discovery of Cannabinoid Glycosides

LOS ANGELES, CA -- (Marketwired) -- 02/01/17 -- (OTCQB: VBIO) ("Vitality Biopharma", "Vitality", or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the publication of a scientific manuscript that details internal research efforts including the discovery and production of cannabinoid glyc ...


01.02.2017

Vitality Biopharma to Present at Biotech Showcase 2017

LOS ANGELES, CA -- (Marketwired) -- 01/09/17 -- (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced that it will present at the Ninth Annual Biotech Showcase 2017 Conference, on January 11, at the Hilton San Francisco Union Square.Company CE ...


09.01.2017

Vitality Biopharma Advances Cannabosides for Treatment of Narcotic Bowel Syndrome

LOS ANGELES, CA -- (Marketwired) -- 11/16/16 -- (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced that it is advancing its cannabosides pharmaceuticals for treatment of narcotic bowel syndrome, a severe form of opiate-induced abdominal pain.Every day more than 650,000 op ...


16.11.2016

Vitality Biopharma Announces International Patent Filing for Cannabinoid Pharmaceuticals

LOS ANGELES, CA -- (Marketwired) -- 11/09/16 -- (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the filing of an international PCT patent application, a milestone in its development of a platform of cannabinoid pharmaceuticals.The Patent Cooperation Treaty (PCT) is an ...


09.11.2016

Vitality Biopharma Reports on Initial Cannabinoid Drug Formulation Studies

LOS ANGELES, CA -- (Marketwired) -- 10/19/16 -- (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced results of recent drug formulation studies that documented substantial modifications to key physiochemical properties of cannabinoids through ...


19.10.2016

Vitality Biopharma Develops Cannabinoid Alternatives to Opiate Prescription Pain Medications

LOS ANGELES, CA -- (Marketwired) -- 09/13/16 -- (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, wishes to advise that a written by Robert Brooke, Company CEO, sheds new light on key factors in the fight against the increasing epidemic of prescription painkiller related deaths.In his ...


13.09.2016

Vitality Biopharma to Present at Rodman & Renshaw 18th Annual Global Investment Conference

LOS ANGELES, CA -- (Marketwired) -- 09/12/16 -- (OTCQB: VBIO) ("Vitality" or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders announced today that Company CEO, Robert Brooke will be presenting at the Rodman & Renshaw 18th Annual Global Investment Conference to be held September 12, 2016, at the Lotte New York Pa ...


12.09.2016

Vitality Biopharma Announces Expansion of Prodrug Pharmaceutical Portfolio

LOS ANGELES, CA -- (Marketwired) -- 08/24/16 -- (OTCQB: VBIO) ("Vitality" or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced a significant expansion of its glycoside prodrug intellectual property portfolio through the filing of U.S. patent application 62/363,808, which expands upon two previous pat ...


24.08.2016

Vitality Biopharma Begins Trading Under New Stock Symbol "VBIO"

LOS ANGELES, CA -- (Marketwired) -- 08/17/16 -- (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, is pleased to announce that effective immediately, its common stock now trades on the over-the-counter market under the symbol "VBIO."Trading of the company''s stock und ...


17.08.2016

Vitality Biopharma Advances Cannabosides for Treatment of Inflammatory Bowel Disease

LOS ANGELES, CA -- (Marketwired) -- 07/27/16 -- (OTCQB: STVFD) ("Vitality" or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced updates to its clinical development plans including the advancement of cannabosides for the treatment of inflammatory bowel disease.Vitality Biopharma has developed a new cl ...


27.07.2016

Vitality Biopharma Name Change and Corporate Actions Receive Shareholder Approval

LOS ANGELES, CA -- (Marketwired) -- 07/19/16 -- (OTCQB: STVF) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced shareholder approval and the effective date of a 1-for-10 reverse stock split and a concurrent name change from Stevia First Corp. to Vitality Biopharma, Inc.The reverse sto ...


19.07.2016

Vitality Biopharma to Present at LD Micro and BIO Conferences

LOS ANGELES, CA -- (Marketwired) -- 06/01/16 -- Vitality Biopharma, Inc. (OTCQB: STVF), a company dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced that Company CEO Mr. Robert Brooke will be presenting and meeting with investors at the upcoming 2016 LD Micro Invitational and BIO International Conference in June.Vitality Biopharma to present on Tuesd ...


01.06.2016

RespireRx Pharmaceuticals Inc. Files March 31, 2016 Quarterly Report on Form 10-Q

GLEN ROCK, NJ -- (Marketwired) -- 05/16/16 -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the development of medicines for respiratory disorders, including sleep apneas and drug-induced respiratory depression, has filed its March 31, 2016 Quarterly Report on Form 10-Q and is hereby providing an update on the Company''s ongoing clinical trials, financing activities and its plans for the remainder of 2016.James S. Manuso, ...


16.05.2016

Launch of Vitality Biopharma for Cannabinoid Prodrug Pharmaceutical Development

LOS ANGELES, CA -- (Marketwired) -- 05/09/16 -- (OTCQB: STVF) (the "Company") is pleased to announce that it is changing its name to Vitality Biopharma, Inc. and that the Company will be dedicated to development of cannabinoid prodrug pharmaceuticals, and unlocking the power of cannabinoids for treatment of serious neurological and inflammatory disorders.In a recent shareholder letter available on the new corporate website at: , the Company''s CEO, Robert Brooke, stated, &q ...


09.05.2016

RespireRx Pharmaceuticals Inc. to Present at the 28th Annual Roth Conference on March 15, 2016

GLEN ROCK, NJ -- (Marketwired) -- 03/11/16 -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the development of medicines for respiratory disorders, including sleep apneas and drug-induced respiratory depression, announced that the Company''s President and CEO, and Vice Chairman of the Board of Directors, James S. Manuso, Ph.D., will present at the 28th Annual Roth Conference () on Tuesday, March 15, 2016 at 5:30 PM Pacific ...


11.03.2016

RespireRx Pharmaceuticals Inc. to Present at 8th Annual Biotech Showcase(TM) 2016

GLEN ROCK, NJ -- (Marketwired) -- 01/11/16 -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (as of January 11, 2016; previously OTCQB: CORX) ("RespireRx" or the "Company"), a leader in developing drugs for respiratory disorders, particularly sleep apneas and drug-induced respiratory depression, announces that the Company''s President, Chief Executive Officer and Vice Chairman of the Board of Directors, James S. Manuso, Ph.D., will present at The Biotech Showcase™ on ...


11.01.2016

Stevia Corp. Announces Real Hemp LLC''s Collaboration With Internationally Recognized Designer and the Rubber Killer(R) Brand

INDIANAPOLIS, IN -- (Marketwired) -- 10/21/15 -- (OTC PINK: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, is pleased to announce that its wholly-owned subsidiary, Real Hemp LLC will be collaborating with the Rubber Killer brand to introduce a line of eco-friendly, high fashion and functio ...


21.10.2015

Cortex Pharmaceuticals, Inc. to Present at the 14th Annual BIO Investor Forum

GLEN ROCK, NJ -- (Marketwired) -- 10/19/15 -- Cortex Pharmaceuticals, Inc. (OTCQB: CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, particularly obstructive and central sleep apneas and drug-induced respiratory depression, announces that it will be presenting at the 14th Annual BIO Investor Forum (). The conference is being sponsored by the Biotechnology Industry Organization and is being held on October 20 - 21, 2015 at the Parc 55 ...


19.10.2015

Stevia Corp. Reports on Budget Hemp''s Better Than Expected Sales Numbers Following Launch of Online Store

INDIANAPOLIS, IN -- (Marketwired) -- 09/15/15 -- (OTC PINK: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, is pleased to provide an update on initial sales of its wholly-owned subsidiary, Real Hemp LLC''s, Budget Hemp™ online store following its launch on August 6, 2015, as well ...


15.09.2015

Stevia Corp. Reports on Initial Sales Trends for Realhemp(TM) Branded Product Lines

INDIANAPOLIS, IN -- (Marketwired) -- 09/10/15 -- (OTC PINK: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, is pleased to provide an update on the initial success of its wholly-owned subsidiary Real Hemp LLC''s Realhemp™ product lines.On August 3, 2015, Stevia Corp announced the u ...


10.09.2015

Cortex Pharmaceuticals, Inc. to Present at Rodman & Renshaw 17th Annual Global Investment Conference

GLEN ROCK, NJ -- (Marketwired) -- 09/08/15 -- Cortex Pharmaceuticals, Inc. (OTCQB: CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, particularly obstructive sleep and central apneas and drug-induced respiratory depression, announces that it will be presenting at the Rodman & Renshaw 17th Annual Global Investment Conference (). The conference is being sponsored by H.C. Wainwright & Co. and is being held on September 8 - 10, 20 ...


08.09.2015

Cortex Pharmaceuticals, Inc. Announces Initial Closing of Private Placement

GLEN ROCK, NJ -- (Marketwired) -- 08/31/15 -- Cortex Pharmaceuticals, Inc. (OTCQB: CORX) ("Cortex" or the "Company") today announced an initial closing of $721,180 under a private placement of up to $3 million of units at $0.02103 per unit. The Company sold 34,292,917 units, consisting of one share of common stock and one warrant to purchase two additional shares of common stock. The warrants are exercisable through September 30, 2020 and entitle the holders thereof to purch ...


31.08.2015

Cortex Pharmaceuticals, Inc. Announces Appointment of James S. J. Manuso, Ph.D., as President and Chief Executive Officer, Vice Chairman of the Board of Directors

GLEN ROCK, NJ -- (Marketwired) -- 08/19/15 -- Cortex Pharmaceuticals, Inc. (OTCQB: CORX) ("Cortex" or the "Company"), a leader in the discovery and development of innovative pharmaceuticals for the treatment of breathing disorders, today announced the appointment of James S. J. Manuso, Ph.D., 66, as President and Chief Executive Officer, as well as Vice Chairman and a member of the Board of Directors, of the Company. Dr. Manuso also has agreed to subscribe to purchase newly ...


19.08.2015

Stevia Corp. Launches Its Bulk Hemp Products Online Store at www.BudgetHemp.com for Commercial Buyers

INDIANAPOLIS, IN -- (Marketwired) -- 08/06/15 -- (OTC PINK: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, is pleased to announce that its wholly-owned subsidiary Real Hemp LLC has launched its second online store at , featuring hemp products targeted to commercial customers.The initial Bu ...


06.08.2015

Stevia Corp. Launches Its Online Store at www.RealhempStore.com Featuring Realhemp(TM) Branded Food and Skincare Product Lines

INDIANAPOLIS, IN -- (Marketwired) -- 08/03/15 -- (OTC PINK: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds is pleased to announce that its wholly-owned subsidiary Real Hemp LLC has launched its online store at featuring Realhemp™ branded food and skincare product lines targeted to retail c ...


03.08.2015

Stevia Corp. Provides Update on 10-K Filing

INDIANAPOLIS, IN -- (Marketwired) -- 08/03/15 -- (OTC PINK: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds is providing an update for its pending 10-K filing.The Company''s annual 10-K filing for the fiscal year period ending March 31, 2015 was due to be filed on June 30, 2015. Th ...


03.08.2015

Stevia Corp. Discusses Partnership Plans While Continuing to Implement a Broad Intellectual Property and Commercial Strategy Related to Cannabis and Industrial Hemp

INDIANAPOLIS, IN -- (Marketwired) -- 05/21/15 -- (OTCQB: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds is pleased to announce the filing of a sixth provisional patent application with the United States Patent and Trademark Office (USPTO) for the treatment of sleep and anxiety disorders usi ...


21.05.2015

Stevia Corp. Names Famed Cannabis Researcher and Former Indiana University Professor Paul Mahlberg to Its Advisory Panel

INDIANAPOLIS, IN -- (Marketwired) -- 04/28/15 -- (OTCQB: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds is pleased to announce the addition of Dr. Paul Mahlberg to Stevia Corp.''s newly formed Advisory Panel.Dr. Mahlberg obtained one of only two Drug Enforcement Administration (DE ...


28.04.2015

Stevia Corp Welcomes Biochemist and Former MD Anderson Cancer Researcher Dennis Hill to Its Newly Formed Advisory Panel

INDIANAPOLIS, IN -- (Marketwired) -- 04/20/15 -- Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, is pleased to announce that biochemist and former MD Anderson Cancer Researcher Dennis Hill has accepted a position on Stevia Corp.''s newly formed Advisory Panel. ...


20.04.2015

Stevia Corp. on Track for Another Record Harvest

INDIANAPOLIS, IN -- (Marketwired) -- 04/15/15 -- Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, is pleased to announce that the Company''s 2015 spring harvest is on track to exceed 3,000 tons, achieving a 50% increase over the 2014 spring harvest and a 300% in ...


15.04.2015

Stevia Corp. Files Provisional Patent With the United States Patent and Trademark Office for a Non-Invasive and Simple to Use Delivery System for Cannabinoids

INDIANAPOLIS, IN -- (Marketwired) -- 03/06/15 -- (OTCQB: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds is pleased to announce the filing of a provisional patent with the United States Patent and Trademark Office (USPTO) for a non-invasive, simple to use delivery system for cannabinoids whi ...


06.03.2015

Stevia Corp. Files Two Additional Provisional Patent Applications With the United States Patent and Trademark Office for a Cannabidiol (CBD) and Aspirin Formulation and a Cannabidiol and Naproxen Formulation to Treat Pain and Cardiovascular Disease

INDIANAPOLIS, IN -- (Marketwired) -- 01/29/15 -- (OTCQB: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, is pleased to announce the filing of two additional provisional patent applications with the United States Patent and Trademark Office (USPTO) for the treatment of pain and cardiovascula ...


29.01.2015

Stevia Corp. Provides Spring Harvest Guidance

INDIANAPOLIS, IN -- (Marketwired) -- 01/28/15 -- (OTCQB: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, is pleased to announce that the company expects the current 2015 spring harvest to exceed 3,000 tons achieving a 50% increase over the 2014 spring harvest and a 300% increase over the 20 ...


28.01.2015

Stevia Corp. Announces Investor Update Conference Call

INDIANAPOLIS, IN -- (Marketwired) -- 01/26/15 -- (OTCQB: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, is pleased to announce that the company will host a conference call on January 29, 2015 at 4:30 PM EST to discuss recent corporate news and its business goals for 2015. All shareholders ...


26.01.2015

Good Things Come in Little Packages: Little Goodies Set to Break Ground on New MMJ Cultivation Site in Phoenix, AZ

PHOENIX, AZ -- (Marketwired) -- 01/23/15 -- Little Goodies , Arizona''s premier source for ultra-premium, medical-grade cannabis flowers and edibles, is pleased to announce that they will be breaking ground on a state-of-the-art cultivation facility in Phoenix in early 2015.Since it was legalized in Arizona in 2010, medical marijuana has helped thousands of patients suffering from debilitating diseases find comfort and solace through natural medicine. Concurrent and ongoing studies ha ...


23.01.2015

Stevia Corp. Files Key Provisional Patent Application With the United States Patent and Trademark Office for Cannabidiol (CBD) and Acetaminophen Formulation to Treat Pain

INDIANAPOLIS, IN -- (Marketwired) -- 01/15/15 -- (OTCQB: STEV)(OTCQB: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, is pleased to announce the filing of an important provisional patent application with the United States Patent and Trademark Office for the treatment of pain using acetamino ...


15.01.2015

Stevia Corp. Appoints Dr. Jerry Smartt to Board of Directors and Welcomes Veteran Research Scientist to Advisory Board

INDIANAPOLIS, IN -- (Marketwired) -- 01/12/15 -- (OTCQB: STEV) ("Stevia Corp" or the "Company"), an international farm management company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their extracts, is pleased to announce the appointment of Dr. Jerry W Smartt Jr. to its Board of Directors and Prof. Xie Haihui as research advisor.Dr. Smartt is a board-certified neurologist and established Smartt Neurology, P ...


12.01.2015

Stevia Corp. Confirms Protocol to Produce Synthetic CBD

INDIANAPOLIS, IN -- (Marketwired) -- 12/22/14 -- (OTCQB: STEV) ("Stevia Corp" or the "Company"), an international farm management company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their extracts, is pleased to announce the Company''s Hong Kong subsidiary, Stevia Technew Ltd, has confirmed a cost effective protocol to produce synthetic cannabidiol (CBD) that is molecularly equivalent to CBD extr ...


22.12.2014

Cannabis Therapy Corp. to Present at SeeThruEquity MicroCap Investor Forum November 12th in NYC

BOULDER, CO -- (Marketwired) -- 11/07/14 -- (OTCQB: CTCO) (the "Company"), a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, cannabinoid-based medicinal therapies and supplements (Nutraceuticals), today announced that Company CEO Dr. Soren Mogelsvang PhD and CFO Mr. Arnold Tinter will be presenting at upcoming fall 2014 , being held at New York City''s on November 12, 2014 at 10:00 A.M. Eastern.C ...


07.11.2014

Stevia Corp. on Track for Another Record Harvest in Spring 2015

INDIANAPOLIS, IN -- (Marketwired) -- 11/05/14 -- (OTCQB: STEV) ("Stevia Corp" or the "Company"), an international farm management company focused on the commercial development of natural products that support a healthy lifestyle, including stevia and hemp and their extracts, is pleased to announce the anticipated 2015 spring harvest is on track to exceed the 2014 spring harvest which more than doubled the 2013 spring harvest.In addition, the Company is developing new core pr ...


05.11.2014

RespireRx Pharmaceuticals Inc. Files September 30, 2016 Quarterly Report on Form 10-Q

GLEN ROCK, NJ -- (Marketwired) -- 11/15/16 -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the development of medicines for respiratory disorders, including sleep apneas and drug-induced respiratory depression, has filed its September 30, 2016 Quarterly Report on Form 10-Q and is hereby providing an update on the Company''s ongoing clinical trials and other matters.James S. Manuso, Ph.D., President, Chief Executive Office ...


15.11.2016

RespireRx Pharmaceuticals Inc. Announces 1-for-325 Reverse Stock Split

GLEN ROCK, NJ -- (Marketwired) -- 09/01/16 -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the development of medicines for respiratory disorders, including sleep apneas and drug-induced respiratory depression, today announced that the Company is effecting the one-for-three-hundred-twenty-five reverse stock split of the Company''s issued and outstanding common stock (the "Reverse Split") that was approved by the ...


01.09.2016



All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 41


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.